Enliven Therapeutics
ELVN
ELVN
121 hedge funds and large institutions have $984M invested in Enliven Therapeutics in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $1.12B → $984M (-$133M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
81% less call options, than puts
Call options by funds: $4K | Put options by funds: $21K
Holders
121
Holding in Top 10
7
Calls
$4K
Puts
$21K
Top Buyers
| 1 | +$9.25M | |
| 2 | +$7.66M | |
| 3 | +$5.02M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.75M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.24M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$6.05M | |
| 3 | -$3.94M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.72M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$3.55M |
